Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Classifica tra le azioni #830
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Prezzo delle azioni
$71.40
Capitalizzazione di mercato
$29.93B
Variazione (1 giorno)
-0.13%
Variazione (1 anno)
-51.06%
Paese
US
Scambia Zoetis Inc. (ZTS)

Categoria

Rapporto P/E per Zoetis Inc. (ZTS)
Rapporto P/E al September 2026 TTM: 12.12
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Zoetis Inc., il rapporto P/E attuale (TTM) è 12.12. Alla fine del 2023, il rapporto P/E era 38.83.
Storico del rapporto P/E per Zoetis Inc. da 2009 a 2026
Rapporto P/E alla fine di ogni anno
Anno Rapporto P/E Cambia
2026 (TTM) 12.12 -59.29%
2024 29.77 -23.34%
2023 38.83 19.46%
2022 32.51 -42.80%
2021 56.83 18.28%
2020 48.04 13.88%
2019 42.19 45.79%
2018 28.94 -29.16%
2017 40.85 26.39%
2016 32.32 -54.24%
2015 70.64 91.00%
2014 36.98 14.03%
2013 32.43 -8.80%
2012 35.56 -41.24%
2011 60.52 -55.10%
2010 134.79 -190.91%
2009 -148.27 0.00%
Rapporto P/E per aziende simili o concorrenti
Azienda P/E Ratio Differenza del P/E Ratio Il paese
38.12 214.53%
US
30.79 154.06%
US
73.73 508.40%
US
22.25 83.59%
CH
114.95 848.58%
US
Come leggere un P/E ratio?

Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.

Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.

Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.